NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026

Published facts

What the notice says

Buyer

NHS England

Published status

complete

Latest release reference

065041-2026

CPV codes

Common Procurement Vocabulary (CPV) codes: 33600000

Published tags

award, contract

Latest record Bidwake loaded from this source

27 Aug 2026

NHS Branded Medicines Tranche B - Lot 1 - London & South of England - CM/PHR/25/5731 Period of Framework Agreement: 1 September 2026 to 31 August 2028 with an option or option(s) to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months. Lot 2 - Ustekinumab for North of England and Midlands & East, period of Framework Agreement: 1st September 2026 to 31st August 2027 with an option or option(s) to extend for a further 12 months.

Open the official Find a Tender notice

Observed notice trail

How the published record developed

Events follow the publisher date where one is available. “Seen by Bidwake” is the date this service first found the record.

1. Planning notice observed

   21 May 2025

   Latest variant observed by Bidwake on 16 Jul 2026.

   Open this official Find a Tender notice

   Record references

   Release reference

   023859-2025

   Published tags

   planning

2. Planning record updated

   3 Jun 2025

   Latest variant observed by Bidwake on 16 Jul 2026.

   Open this official Find a Tender notice

   Record references

   Release reference

   029487-2025

   Published tags

   planningUpdate

3. Planning notice observed

   14 Jan 2026

   Latest variant observed by Bidwake on 16 Jul 2026.

   Open this official Find a Tender notice

   Record references

   Release reference

   002947-2026

   Published tags

   planning

4. Planning record updated

   18 Feb 2026

   Latest variant observed by Bidwake on 16 Jul 2026.

   Open this official Find a Tender notice

Awards and suppliers

Published award and contract facts

• NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026

  Buyer: NHS EnglandSupplier: ALFASIGMA UK LIMITED

  End date in notice

  31 Aug 2028Date from the linked contract

  Value shown in notice

  £813,863,584Value from the linked contract

  Official source

  Open the official Find a Tender notice for NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026

  About this figure

  • This award names more than one supplier but does not divide the published value between them. The figure is shown for context and is not assigned to one supplier.
  • This figure comes from the linked contract record. Overall totals continue to use the separately published award value.

  View record references

  Source

  Find a Tender

  Award or lot reference

  3

• NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026

  Buyer: NHS EnglandSupplier: Abbvie Ltd

Related evidence

Published terms and linked processes

• Renewal information is statedLot 1Repeated in 4 notices; the most recent statement is shown.Published 18 Feb 2026.Open supporting notice 014706-2026
• Options are statedLot 1

  With an option or option(s) to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months.

  Published 23 Feb 2026.Open supporting notice 016135-2026
• Renewal information is statedLot 1

  With an option or option(s) to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months.

  Published 23 Feb 2026.Open supporting notice 016135-2026
• Options are statedLot 2

  With an option or option(s) to extend (at the Authority’s discretion) for a period or periods up to a total of 12 months.

  Published 23 Feb 2026.Open supporting notice 016135-2026
• Renewal information is statedLot 2

  With an option or option(s) to extend (at the Authority’s discretion) for a period or periods up to a total of 12 months.

  Published 23 Feb 2026.Open supporting notice 016135-2026

No exact source-published process relationship was found.